Developer docs
API playgroundTry for free, no card

Search company profiles

Life Line Screening

Full company profile

uuid0006ziz

Namestring
Life Line Screening
Legal namestring
Life Line Screening of America, Ltd.
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Life Line Screening is a privately held, Ohio-incorporated preventive health screening company founded in 1993, headquartered in Independence, OH with an additional corporate office in Austin, TX and ~1,000 employees. It delivers clinical-grade mobile preventive screenings to asymptomatic adults aged 50+ (and 40+ with cardiovascular risk factors) at 15,000+ community events annually across 48 contiguous states plus Puerto Rico, screening 600,000–700,000 people per year and 11M+ lifetime. Service is delivered by in-house ultrasound, EKG and finger-stick blood technicians with results processed by a CLIA-accredited laboratory and reviewed by a board-certified physician before delivery, with HSA/FSA-eligible tiered packages priced from $186 (Heart & Stroke Risk, 4 screenings) up to $483 (Complete Preventative Care Suite, 19 screenings) and a $499 p-tau217 Alzheimer's biomarker add-on launched in 2026.

The product surface is organized around modular individual screenings (carotid artery ultrasound, abdominal aortic aneurysm, 6-lead EKG atrial fibrillation, ankle-brachial index PAD, pulse-echo ultrasound bone density, 6 for Life risk score, liver, kidney, A1C, hs-CRP, lipid panel, vitamin D, PSA, testosterone, colorectal) bundled into four escalating packages and an annual OneLife membership at $197/year that builds a longitudinal personal health record with mid-year follow-up, physician review and live clinical consultation. At-home Life Line Home Tests extend the brand into a separate D2C kit line, and a parallel B2B channel distributes corporate vouchers and on-site events to self-insured employers, unions, first responders, hospitals and health plans through an enterprise storefront. Recent moves include the 2026 strategic partnership with Lucent Diagnostics (Quanterix) to integrate Simoa-powered blood-based biomarker testing into the mobile network, and an executive refresh led by CEO Matt Miller and CFO Kevin Vass (both ex-StudyKIK).

Short descriptiontext

Life Line Screening is a privately held mobile preventive health screening company founded in 1993 that delivers clinical-grade cardiovascular, metabolic and Alzheimer's screenings to ~650,000 adults annually at 15,000+ community events across the U.S. via tiered packages, an annual OneLife membership and corporate partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersIndependence, United States
HQ citystring
Independence
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preventive health screening, mobile diagnostic services, cardiovascular screening, vascular ultrasound imaging, wellness screening services
Industry1 code
SECONDARYEDACAMAJ
Health Screening & Preventive Care Programs (Vision/Hearing/Immunization)
Education/Early Childhood Education/Health and Nutrition Programs for Young Children
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Preventive Health Screening Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1One-time preventive screening packages
TypeTransaction Fee
Description

Per-visit payment for tiered screening packages (Heart & Stroke Risk $186, Chronic Disease Risk $285, Men's & Women's Health $384, Complete Preventative Care Suite $483, plus add-ons such as the $499 p-tau217 Alzheimer's test). HSA/FSA eligible; no insurance filed.

lifelinescreening.com
2OneLife annual membership
TypeSubscription Recurring
Description

Recurring $197/year subscription that bundles annual cardiovascular and stroke screening, men's and women's essentials, VIP scheduling, free physician review, live clinical consultation, $30 specialty blood-test credit, and discounted family members at $167.

lifelinescreening.com
3Corporate screening vouchers and partnership screenings
TypeTransaction Fee
Description

Bulk sale of screening vouchers and private on-site screening events sold to corporations, unions, first responders, self-insured employers, hospitals, insurance companies and health plans via enterprise.lifelinescreening.com.

lifelinescreening.com
4Life Line Home Tests
TypeOne Time License
Description

Direct-to-consumer at-home test kits (physician-ordered) sold through the website, with kit replacement policy and a third-party physician network providing lab authorization.

lifelinescreening.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Pricing details7 tiers
1Heart & Stroke Risk package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$186 per visit for 4 screenings + physician review (carotid artery, abdominal aortic aneurysm, peripheral artery disease, atrial fibrillation).

lifelinescreening.com
2Chronic Disease Risk package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$285 per visit for 10 screenings + physician review; includes all Heart & Stroke tests plus chronic disease risk assessment.

lifelinescreening.com
3Men's & Women's Health package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$384 per visit for 15 screenings + physician review; adds liver, kidney, hormone, organ health and A1C testing; marked Most Popular.

lifelinescreening.com
4Complete Preventative Care Suite
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$483 per visit for 19 screenings + physician review; includes every screening plus mid-year follow-up assessment.

lifelinescreening.com
5p-tau217 Alzheimer's blood biomarker test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$499 standalone add-on blood test; supports clinical evaluation of Alzheimer's-related amyloid changes; results in ~15 days; for adults 55+.

lifelinescreening.com
6OneLife annual membership
ModelSubscriptionBilling cadenceAnnual
Notes

$197/year; annual cardiovascular & stroke screening, men's/women's essentials, live clinical consultation, VIP scheduling, free physician review, free osteoporosis & cortisol tests ($158 value), $30 specialty blood-test credit; family members $167 each ($30 discount).

lifelinescreening.com
7Promotional pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Up to 50% off regular package pricing appears as a special offer on the find-a-location page; cancellation within 48 hours of appointment forfeits $50 from refund gift card (OneLife members exempt).

lifelinescreening.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1OneLife
Description

Annual membership program offering comprehensive cardiovascular and stroke risk health screenings, member benefits, and ongoing wellness tracking for $197/year.

lifelinescreening.com
+1 more record
Core offering1 text field

Life Line Screening delivers clinical-grade preventive health screenings through a mobile community-based delivery model, conducting ultrasound, EKG, finger-stick blood, bone density and blood biomarker tests at 15,000+ community events annually across the United States. Screenings are performed by in-house technicians, processed by a CLIA-accredited laboratory, and reviewed by board-certified physicians before results are delivered. Offerings are sold both directly to individual consumers via tiered screening packages and an annual membership, and to organizations via a separate enterprise channel.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 125,000+ lives saved cumulatively
+4 more records
Product overview1 text field

Life Line Screening operates a single unified preventive health screening platform (a mobile community-based screening service, not a software platform) composed of modular individual screenings, tiered screening packages, and the OneLife annual membership. The portfolio is organized around four escalating screening packages — Heart & Stroke Risk ($186), Chronic Disease Risk ($285), Men's & Women's Health ($384), and the Complete Preventative Care Suite ($483) — each adding more individual screenings on top of the prior tier. The underlying individual screening modules include the four flagship cardiovascular tests (Carotid Artery, Abdominal Aortic Aneurysm, Atrial Fibrillation via 6-lead EKG, and Peripheral Artery Disease via ABI), blood-based metabolic and organ tests (Liver Function, Kidney Function, A1C, Vital Organ Panel, hs-CRP, Complete Lipid Panel, Vitamin D), the 6 for Life risk-score assessment, Osteoporosis bone density ultrasound, colorectal screening, PSA/Prostate, and the new p-tau217 Alzheimer's biomarker blood test ($499). The OneLife Membership bundles these into an annual recurring subscription ($197/year) with physician review, VIP scheduling, and a live clinical consultation. At-home Life Line Home Tests extend the brand into a separate direct-to-consumer product line. All screenings are conducted by Life Line Screening's mobile medical teams at over 15,000 community events annually across the U.S., with samples processed by a CLIA-accredited lab and results reviewed by board-certified physicians.

Product and service6 records
1Tiered Mobile Preventive Screening Packages
CategoryPreventive health screening packages
Description

Tiered preventive care packages (Heart & Stroke Risk at $186, Chronic Disease Risk at $285, Men's & Women's Health at $384, Complete Preventative Care Suite at $483) bundling ultrasound, EKG, finger-stick blood and bone density screenings with board-certified physician review; available to adults 50+ or 40+ with risk factors at mobile community events nationwide.

2p-tau217 Alzheimer's Biomarker Test
CategoryAdd-on blood-based biomarker screening
Description

Standalone add-on blood test screening for the p-tau217 biomarker associated with Alzheimer's disease; intended to support (not replace) clinical evaluation, priced at $499 and available at select mobile screening locations for adults 55+.

3OneLife Annual Membership
CategorySubscription / membership program
Description

Annual $197/year subscription membership providing annual cardiovascular and stroke screenings, gender-specific essentials (thyroid and osteoporosis screening for women; testosterone and prostate cancer screening for men), VIP scheduling, complimentary physician review, live clinical consultation, $30 credit toward specialty blood tests, free osteoporosis and cortisol tests, and discounted family member add-on at $167.

4Life Line Home Tests
CategoryAt-home test kit product line
Description

Trademarked direct-to-consumer at-home health test kit line sold through the website, requiring physician order through a third-party affiliated physician network; available only in the United States with kit replacement policy.

5Corporate Enterprise Screening Solutions
CategoryCorporate wellness and partnership screening
Description

B2B offering sold via enterprise.lifelinescreening.com that delivers bulk screening vouchers, on-site private screening events and partnership programs to corporations, unions, first responders, self-insured employers, hospitals, insurance companies and health plans to identify employee health risks and reduce healthcare claims.

66 for Life Health Screening Assessment
CategoryIndividual screening (blood-based risk assessment)
Description

Finger-stick blood test plus health questionnaire producing a Risk Score (0-100) for 5-year likelihood of developing heart disease, stroke, congestive heart failure, diabetes, COPD and lung cancer, based on a predictive algorithm grounded in the Framingham Heart Study and 100+ clinical studies.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Tempus AI
Strategic tierMinor (Mentioned As Co-Collaborator In Quanterix Alzheimer'S Initiative)TypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Mentioned alongside Life Line Screening as strategic collaborators with Quanterix to expand access to blood-based Alzheimer's biomarker tests. Direct partnership details between Tempus AI and Life Line Screening are not specified in the source material.

stocktitan.net
2Lucent Diagnostics (a brand of Quanterix Corporation)
Strategic tierFlagship Strategic PartnershipTypeTechnology or IntegrationAnnounced on2026-03-01
Description

Lucent Diagnostics and Life Line Screening announced a collaboration to expand access to Lucent's Simoa-powered blood-based biomarker tests (including the p-tau217 Alzheimer's test) through Life Line Screening's mobile community events. Life Line Screening is integrating Lucent's tests into its network of over 15,000 community events annually across 48 contiguous states, starting with Florida, California and Texas, to enable earlier detection of cognitive disease and chronic conditions outside clinical settings.

clpmag.com
3Hospital systems (Hospital Partnerships)
Strategic tierCore Channel Partner TypeTypeChannel Partner/ Reseller/ Distributor
Description

Life Line Screening acts as an extension of hospitals' community outreach, helping transition screening participants into hospital patients and generating downstream revenue for the health system while closing the continuum of care.

lifelinescreening.com
Strategic tierCore Channel Partner TypeTypeChannel Partner/ Reseller/ Distributor
Description

Corporate partnerships and corporate screening vouchers sold through enterprise.lifelinescreening.com help identify employee health risks, reduce claims, and improve workforce wellness with actionable data.

5Unions and first-responder organizations
Strategic tierCore Channel Partner TypeTypeChannel Partner/ Reseller/ Distributor
Description

Listed as named partner categories; example customer is Fraternal Order of Police Chicago Lodge 7, whose president John Catanzara Jr. provided a testimonial about screenings catching issues early and limiting city healthcare costs.

lifelinescreening.com
Strategic tierCore Channel Partner TypeTypeStrategic or Co-development Partner
Description

Health plans can partner with Life Line Community Healthcare (an affiliated entity) to close care gaps for Medicare beneficiaries; life insurers and health plans are listed as named partner categories.

Strategic tierSupporting Partner TypeTypeImplementation/ SI/ Consulting Partner
Description

Life Line Screening works directly with companies and healthcare providers to collect specimens/samples nationwide, leveraging its equipment inventory and reach.

Strategic tierSupporting Partner TypeTypeGTM or Marketing Partner
Description

Operates an Affiliates program (lifelinescreeningaffiliates.com) for co-branded referral marketing to drive bookings.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Quest Diagnostics is the largest U.S. clinical laboratory network, offering a broad menu of preventive and diagnostic blood tests. It is comparable to Life Line Screening's CLIA-accredited lab and finger-stick blood work and represents the most likely insurance-covered substitute for Life Line's cash-pay blood-based screenings.

TypeBroad incumbent
Description

Labcorp is a major U.S. clinical lab network with a broad preventive and routine blood-testing menu. Comparable to Life Line's blood-based metabolic, organ, hormone, and A1C panels and serves as a primary-care-referred substitute for Life Line's finger-stick offerings.

TypeDirect peer
Description

Function Health is a direct-to-consumer preventive health membership that sells a comprehensive annual blood-testing panel and biomarker tracking. Directly comparable to Life Line's OneLife annual membership and p-tau217 add-on test as a DTC preventive-blood-testing brand targeting health-conscious adults.

TypeDirect peer
Description

InsideTracker is a DTC personalized health and wellness platform built around blood-biomarker testing and longitudinal tracking. Comparable to Life Line's 6 for Life assessment and OneLife longitudinal record as a blood-test-driven, prevention-focused consumer health brand.

TypeDirect peer
Description

AnyLabTestNow is a direct-to-consumer retail lab-testing franchise offering thousands of tests without a doctor's order. Closely comparable to Life Line's no-referral, cash-pay, walk-in preventive testing model and is a primary alternative for consumers who prefer retail-store convenience over mobile events.

TypeDirect peer
Description

Walk-In Lab is an online direct-to-consumer lab-testing marketplace that lets consumers order their own blood tests without a physician visit. Comparable to Life Line's no-referral, cash-pay model and to its Life Line Home Tests at-home kit line.

TypeDirect peer
Description

Mobile Health is a national on-site occupational health and screening provider that brings screenings directly to employer worksites. Comparable to Life Line's enterprise B2B mobile-screening model serving employers, unions, and first responders, although Mobile Health's emphasis is occupational health rather than preventive cardiovascular screening.

TypeEmerging player
Description

Color Health is a population health and preventive testing company offering genetic, infectious disease, and most recently blood-based cancer screening at scale. Comparable to Life Line's expanding blood-based biomarker offerings (including p-tau217) and to its employer and health-plan distribution motion, though Color's focus is genetics and cancer rather than cardiovascular ultrasound.

TypeEmerging player
Description

Parsley Health is a membership-based preventive primary care practice that pairs advanced biomarker testing with ongoing clinical care. Comparable to Life Line's OneLife membership in combining longitudinal health tracking with preventive testing, although Parsley delivers via telehealth and clinic visits rather than mobile community events.

TypeOthers
Description

Quanterix, through its Lucent Diagnostics brand, is Life Line Screening's announced strategic partner for p-tau217 Alzheimer's blood-based biomarker testing. Quanterix is the underlying technology provider whose Simoa platform powers the Alzheimer's test, making it a key ecosystem partner rather than a direct competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Life Line Screening

Preventive Health Screening Serviceslifelinescreening.com

Life Line Screening is a privately held mobile preventive health screening company founded in 1993 that delivers clinical-grade cardiovascular, metabolic and Alzheimer's screenings to ~650,000 adults annually at 15,000+ community events across the U.S. via tiered packages, an annual OneLife membership and corporate partnerships.

What Life Line Screening does

Life Line Screening is a privately held, Ohio-incorporated preventive health screening company founded in 1993, headquartered in Independence, OH with an additional corporate office in Austin, TX and ~1,000 employees. It delivers clinical-grade mobile preventive screenings to asymptomatic adults aged 50+ (and 40+ with cardiovascular risk factors) at 15,000+ community events annually across 48 contiguous states plus Puerto Rico, screening 600,000–700,000 people per year and 11M+ lifetime. Service is delivered by in-house ultrasound, EKG and finger-stick blood technicians with results processed by a CLIA-accredited laboratory and reviewed by a board-certified physician before delivery, with HSA/FSA-eligible tiered packages priced from $186 (Heart & Stroke Risk, 4 screenings) up to $483 (Complete Preventative Care Suite, 19 screenings) and a $499 p-tau217 Alzheimer's biomarker add-on launched in 2026.

The product surface is organized around modular individual screenings (carotid artery ultrasound, abdominal aortic aneurysm, 6-lead EKG atrial fibrillation, ankle-brachial index PAD, pulse-echo ultrasound bone density, 6 for Life risk score, liver, kidney, A1C, hs-CRP, lipid panel, vitamin D, PSA, testosterone, colorectal) bundled into four escalating packages and an annual OneLife membership at $197/year that builds a longitudinal personal health record with mid-year follow-up, physician review and live clinical consultation. At-home Life Line Home Tests extend the brand into a separate D2C kit line, and a parallel B2B channel distributes corporate vouchers and on-site events to self-insured employers, unions, first responders, hospitals and health plans through an enterprise storefront. Recent moves include the 2026 strategic partnership with Lucent Diagnostics (Quanterix) to integrate Simoa-powered blood-based biomarker testing into the mobile network, and an executive refresh led by CEO Matt Miller and CFO Kevin Vass (both ex-StudyKIK).

Life Line Screening firmographics

Firmographics
Name
Life Line Screening
Legal name
Life Line Screening of America, Ltd.
Website
https://lifelinescreening.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Life Line Screening is a privately held mobile preventive health screening company founded in 1993 that delivers clinical-grade cardiovascular, metabolic and Alzheimer's screenings to ~650,000 adults annually at 15,000+ community events across the U.S. via tiered packages, an annual OneLife membership and corporate partnerships.
Ownership category
akta.pro rank

Where Life Line Screening is headquartered

Location

Headquarters

HQ city
Independence
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Life Line Screening business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. One-time preventive screening packages: Per-visit payment for tiered screening packages (Heart & Stroke Risk $186, Chronic Disease Risk $285, Men's & Women's Health $384, Complete Preventative Care Suite $483, plus add-ons such as the $499 p-tau217 Alzheimer's test). HSA/FSA eligible; no insurance filed.
  2. OneLife annual membership: Recurring $197/year subscription that bundles annual cardiovascular and stroke screening, men's and women's essentials, VIP scheduling, free physician review, live clinical consultation, $30 specialty blood-test credit, and discounted family members at $167.
  3. Corporate screening vouchers and partnership screenings: Bulk sale of screening vouchers and private on-site screening events sold to corporations, unions, first responders, self-insured employers, hospitals, insurance companies and health plans via enterprise.lifelinescreening.com.
  4. Life Line Home Tests: Direct-to-consumer at-home test kits (physician-ordered) sold through the website, with kit replacement policy and a third-party physician network providing lab authorization.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goHeart & Stroke Risk package
Unit PricingPay-as-you-goChronic Disease Risk package
Unit PricingPay-as-you-goMen's & Women's Health package
Unit PricingPay-as-you-goComplete Preventative Care Suite
Unit PricingPay-as-you-gop-tau217 Alzheimer's blood biomarker test
SubscriptionAnnualOneLife annual membership
OtherPay-as-you-goPromotional pricing

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Life Line Screening product offering

Product offering

Core offering

Life Line Screening delivers clinical-grade preventive health screenings through a mobile community-based delivery model, conducting ultrasound, EKG, finger-stick blood, bone density and blood biomarker tests at 15,000+ community events annually across the United States. Screenings are performed by in-house technicians, processed by a CLIA-accredited laboratory, and reviewed by board-certified physicians before results are delivered. Offerings are sold both directly to individual consumers via tiered screening packages and an annual membership, and to organizations via a separate enterprise channel.

Product overview

Life Line Screening operates a single unified preventive health screening platform (a mobile community-based screening service, not a software platform) composed of modular individual screenings, tiered screening packages, and the OneLife annual membership. The portfolio is organized around four escalating screening packages — Heart & Stroke Risk ($186), Chronic Disease Risk ($285), Men's & Women's Health ($384), and the Complete Preventative Care Suite ($483) — each adding more individual screenings on top of the prior tier. The underlying individual screening modules include the four flagship cardiovascular tests (Carotid Artery, Abdominal Aortic Aneurysm, Atrial Fibrillation via 6-lead EKG, and Peripheral Artery Disease via ABI), blood-based metabolic and organ tests (Liver Function, Kidney Function, A1C, Vital Organ Panel, hs-CRP, Complete Lipid Panel, Vitamin D), the 6 for Life risk-score assessment, Osteoporosis bone density ultrasound, colorectal screening, PSA/Prostate, and the new p-tau217 Alzheimer's biomarker blood test ($499). The OneLife Membership bundles these into an annual recurring subscription ($197/year) with physician review, VIP scheduling, and a live clinical consultation. At-home Life Line Home Tests extend the brand into a separate direct-to-consumer product line. All screenings are conducted by Life Line Screening's mobile medical teams at over 15,000 community events annually across the U.S., with samples processed by a CLIA-accredited lab and results reviewed by board-certified physicians.

Differentiator

Problem solved

Functional benefit

Brands

  • OneLife: Annual membership program offering comprehensive cardiovascular and stroke risk health screenings, member benefits, and ongoing wellness tracking for $197/year.
  • Life Line Home Tests

Products and services

  • Tiered Mobile Preventive Screening Packages Tiered preventive care packages (Heart & Stroke Risk at $186, Chronic Disease Risk at $285, Men's & Women's Health at $384, Complete Preventative Care Suite at $483) bundling ultrasound, EKG, finger-stick blood and bone density screenings with board-certified physician review; available to adults 50+ or 40+ with risk factors at mobile community events nationwide.
  • p-tau217 Alzheimer's Biomarker Test Standalone add-on blood test screening for the p-tau217 biomarker associated with Alzheimer's disease; intended to support (not replace) clinical evaluation, priced at $499 and available at select mobile screening locations for adults 55+.
  • OneLife Annual Membership Annual $197/year subscription membership providing annual cardiovascular and stroke screenings, gender-specific essentials (thyroid and osteoporosis screening for women; testosterone and prostate cancer screening for men), VIP scheduling, complimentary physician review, live clinical consultation, $30 credit toward specialty blood tests, free osteoporosis and cortisol tests, and discounted family member add-on at $167.
  • Life Line Home Tests Trademarked direct-to-consumer at-home health test kit line sold through the website, requiring physician order through a third-party affiliated physician network; available only in the United States with kit replacement policy.
  • Corporate Enterprise Screening Solutions B2B offering sold via enterprise.lifelinescreening.com that delivers bulk screening vouchers, on-site private screening events and partnership programs to corporations, unions, first responders, self-insured employers, hospitals, insurance companies and health plans to identify employee health risks and reduce healthcare claims.
  • 6 for Life Health Screening Assessment Finger-stick blood test plus health questionnaire producing a Risk Score (0-100) for 5-year likelihood of developing heart disease, stroke, congestive heart failure, diabetes, COPD and lung cancer, based on a predictive algorithm grounded in the Framingham Heart Study and 100+ clinical studies.

Quantifiable outcome

  • 125,000+ lives saved cumulatively
  • +4 more outcomes

Companies that use Life Line Screening

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Life Line Screening technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability1 record

Feature8 records

Life Line Screening partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor (mentioned as co-collaborator in quanterix alzheimer's initiative), flagship strategic partnership, core channel partner type and supporting partner type.

  • Tempus AIminor (mentioned as co-collaborator in quanterix alzheimer's initiative)Strategic or Co-development Partner · 1 May 2026Mentioned alongside Life Line Screening as strategic collaborators with Quanterix to expand access to blood-based Alzheimer's biomarker tests. Direct partnership details between Tempus AI and Life Line Screening are not specified in the source material.
  • Lucent Diagnostics (a brand of Quanterix Corporation)flagship strategic partnershipTechnology or Integration · 1 March 2026Lucent Diagnostics and Life Line Screening announced a collaboration to expand access to Lucent's Simoa-powered blood-based biomarker tests (including the p-tau217 Alzheimer's test) through Life Line Screening's mobile community events. Life Line Screening is integrating Lucent's tests into its network of over 15,000 community events annually across 48 contiguous states, starting with Florida, California and Texas, to enable earlier detection of cognitive disease and chronic conditions outside clinical settings.
  • Hospital systems (Hospital Partnerships)core channel partner typeChannel Partner/ Reseller/ DistributorLife Line Screening acts as an extension of hospitals' community outreach, helping transition screening participants into hospital patients and generating downstream revenue for the health system while closing the continuum of care.
  • Self-insured employers and corporate wellness programscore channel partner typeChannel Partner/ Reseller/ DistributorCorporate partnerships and corporate screening vouchers sold through enterprise.lifelinescreening.com help identify employee health risks, reduce claims, and improve workforce wellness with actionable data.
  • Unions and first-responder organizationscore channel partner typeChannel Partner/ Reseller/ DistributorListed as named partner categories; example customer is Fraternal Order of Police Chicago Lodge 7, whose president John Catanzara Jr. provided a testimonial about screenings catching issues early and limiting city healthcare costs.
  • Insurance companies and health planscore channel partner typeStrategic or Co-development PartnerHealth plans can partner with Life Line Community Healthcare (an affiliated entity) to close care gaps for Medicare beneficiaries; life insurers and health plans are listed as named partner categories.
  • Healthcare providers and specimen-collection partnerssupporting partner typeImplementation/ SI/ Consulting PartnerLife Line Screening works directly with companies and healthcare providers to collect specimens/samples nationwide, leveraging its equipment inventory and reach.
  • Affiliate and co-brand partners (lifelinescreeningaffiliates.com)supporting partner typeGTM or Marketing PartnerOperates an Affiliates program (lifelinescreeningaffiliates.com) for co-branded referral marketing to drive bookings.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Life Line Screening competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is the largest U.S. clinical laboratory network, offering a broad menu of preventive and diagnostic blood tests. It is comparable to Life Line Screening's CLIA-accredited lab and finger-stick blood work and represents the most likely insurance-covered substitute for Life Line's cash-pay blood-based screenings.
  • Labcorp: Labcorp is a major U.S. clinical lab network with a broad preventive and routine blood-testing menu. Comparable to Life Line's blood-based metabolic, organ, hormone, and A1C panels and serves as a primary-care-referred substitute for Life Line's finger-stick offerings.

Direct peers

  • Function Health: Function Health is a direct-to-consumer preventive health membership that sells a comprehensive annual blood-testing panel and biomarker tracking. Directly comparable to Life Line's OneLife annual membership and p-tau217 add-on test as a DTC preventive-blood-testing brand targeting health-conscious adults.
  • InsideTracker: InsideTracker is a DTC personalized health and wellness platform built around blood-biomarker testing and longitudinal tracking. Comparable to Life Line's 6 for Life assessment and OneLife longitudinal record as a blood-test-driven, prevention-focused consumer health brand.
  • AnyLabTestNow: AnyLabTestNow is a direct-to-consumer retail lab-testing franchise offering thousands of tests without a doctor's order. Closely comparable to Life Line's no-referral, cash-pay, walk-in preventive testing model and is a primary alternative for consumers who prefer retail-store convenience over mobile events.
  • Walk-In Lab: Walk-In Lab is an online direct-to-consumer lab-testing marketplace that lets consumers order their own blood tests without a physician visit. Comparable to Life Line's no-referral, cash-pay model and to its Life Line Home Tests at-home kit line.
  • Mobile Health (mobile occupational health): Mobile Health is a national on-site occupational health and screening provider that brings screenings directly to employer worksites. Comparable to Life Line's enterprise B2B mobile-screening model serving employers, unions, and first responders, although Mobile Health's emphasis is occupational health rather than preventive cardiovascular screening.

Emerging players

  • Color Health: Color Health is a population health and preventive testing company offering genetic, infectious disease, and most recently blood-based cancer screening at scale. Comparable to Life Line's expanding blood-based biomarker offerings (including p-tau217) and to its employer and health-plan distribution motion, though Color's focus is genetics and cancer rather than cardiovascular ultrasound.
  • Parsley Health: Parsley Health is a membership-based preventive primary care practice that pairs advanced biomarker testing with ongoing clinical care. Comparable to Life Line's OneLife membership in combining longitudinal health tracking with preventive testing, although Parsley delivers via telehealth and clinic visits rather than mobile community events.

Others

  • Quanterix Corporation (Lucent Diagnostics): Quanterix, through its Lucent Diagnostics brand, is Life Line Screening's announced strategic partner for p-tau217 Alzheimer's blood-based biomarker testing. Quanterix is the underlying technology provider whose Simoa platform powers the Alzheimer's test, making it a key ecosystem partner rather than a direct competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Life Line Screening social profiles

Digital presence

Life Line Screening compliance and trust

Trust signal

Compliance2 records

Life Line Screening financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Life Line Screening leadership team

Management profile

Number of profiles

Profiles9 records

Life Line Screening subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Life Line Screening funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Life Line Screening M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Life Line Screening

What does Life Line Screening do?

Life Line Screening delivers clinical-grade preventive health screenings through a mobile community-based delivery model, conducting ultrasound, EKG, finger-stick blood, bone density and blood biomarker tests at 15,000+ community events annually across the United States. Screenings are performed by in-house technicians, processed by a CLIA-accredited laboratory, and reviewed by board-certified physicians before results are delivered. Offerings are sold both directly to individual consumers via tiered screening packages and an annual membership, and to organizations via a separate enterprise channel.

Is Life Line Screening a public or private company?

Life Line Screening is a private company. It is classified as unknown and is currently operating.

When was Life Line Screening founded?

Life Line Screening was founded in 1993. It employs 501 to 1,000 people.

Where is Life Line Screening based?

Life Line Screening is headquartered in Independence, United States, in the North America region.

How does Life Line Screening make money?

Four revenue lines are on record. One-time preventive screening packages are the primary driver. The others are oneLife annual membership, corporate screening vouchers and partnership screenings and life Line Home Tests.

Who are Life Line Screening's main competitors?

Broad incumbents on record are Quest Diagnostics and Labcorp. Direct peers are Function Health, InsideTracker, AnyLabTestNow, Walk-In Lab and Mobile Health (mobile occupational health). Emerging players are Color Health and Parsley Health. Quanterix Corporation (Lucent Diagnostics) is listed as an others.

Does Life Line Screening have an API?

No public API is recorded for Life Line Screening.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogQuanterix Releases Financial Results for the First Quarter of 2026Quanterix reported Q1 2026 revenue of $36.4 million, up 20% year-over-year, with adjusted EBITDA loss of $9.8 million. The company expects to reach cash flow breakeven in the second half of 2026 and reaffirmed 2026 revenue guidance of $169–174 million.Clinical Lab ProductsLucent Diagnostics, Life Line Screening Partner for Alzheimer's TestingLucent Diagnostics, a brand of Quanterix Corp, has partnered with Life Line Screening to expand access to blood-based biomarker testing for Alzheimer's disease detection through mobile delivery at community centers, churches, and senior centers nationwide. Life Line Screening will integrate Lucent's Simoa-powered tests into its existing network of over 15,000 community events annually across 48 contiguous states. The collaboration aims to address the estimated 7 million Americans living with Alzheimer's and the additional 6-7 million experiencing mild cognitive impairment symptoms by enabling earlier detection of cognitive disease.Stock TitanQuanterix, Life Line Screening expand Alzheimer’s testsLucent Diagnostics, a brand of Quanterix Corporation, partnered with Life Line Screening to offer blood-based Alzheimer's disease tests across the United States, starting with programs in Florida, California, and Texas. The collaboration aims to promote early detection of cognitive decline through community health initiatives. The tests are designed to be accessible and non-invasive, targeting early intervention.BioSpaceLucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities NationwideLucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening to offer non-invasive blood-based biomarker tests nationally for early detection of chronic conditions including Alzheimer's disease. Life Line Screening will deploy Lucent's tests through its network of over 15,000 community events annually across Florida, California, and Texas, expanding access to diagnostic testing outside clinical settings. The collaboration addresses the estimated 7 million Americans living with Alzheimer's today and aims to identify asymptomatic risks earlier through a mobile delivery model serving both metropolitan and rural communities.GlobeNewswireLife Line Screening (Updated): What You Need to Know?Life Line Screening offers affordable health screenings for cancer, cardiovascular, kidney, and liver diseases across 100 cities and 14,000 locations. Packages range from $159 to $249, with results delivered in about a week. The service is not covered by insurance and may produce false positives.GlobeNewswireLife Line Screening Reviews: What You Need To Know?Life Line Screening, a preventive health screening company founded in 1993, screens over 10 million people annually across 14,000 locations. It offers affordable packages for stroke and cardiovascular disease detection, with about 700,000 events per year. Customer reviews highlight early detection of serious conditions, and the company is not a scam.GlobeNewswireLife Line Screening accelerates its clinical research transformation by appointing Matthew Maxwell as Chief of Clinical Research Strategy.Life Line Screening appointed Matthew Maxwell as Chief of Clinical Research Strategy to lead its clinical research transformation. He will design and implement a strategy to connect patients to clinical trials, leveraging the company's patient engagement platform. The move aims to enhance access to therapies found only in clinical trials.PR NewswireCan You Trust Life Line Screening?Life Line Screening, a preventative health screening company based in Austin, Texas, has published a response defending the value of its services amid division in the medical community over whether asymptomatic screenings are necessary or potentially harmful due to false positives. The article cites Dr. Andy Manganaro, the company's Medical Director, and references statistics from the U.S. Office of the Surgeon General claiming $3.7 billion in medical costs could be saved annually if preventative screenings increased by 90%. The piece, distributed via PRNewswire, functions as promotional content addressing critics rather than reporting on a specific news event.